Skip to main content
Clinical Trials/CTRI/2024/09/074176
CTRI/2024/09/074176CompletedNot Applicable

Prevalence of Sleep Disorders, Associated Academic Performance and Sushupti Intervention: A Randomized Controlled Trial in the Undergraduate Students in Delhi, India

Delhi Pharmaceutical Sciences and Research University1 site in 1 country120 target enrollmentStarted: November 12, 2024Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
120
Locations
1
Primary Endpoint
The primary outcome includes improvement in sleep latency, sleep duration, sleep efficiency, and sleep quality.

Study Overview

Brief Summary

An innovative intervention titled "Sushupti Intervention" will be developed and validated for improving sleep quality. Sushupti is an integrated approach consisting of an education module related to sleep, components of Mind-body intervention, yoga, and Pilate exercises. The intervention will be implemented on students classified as poor sleepers according to the Pittsburgh Sleep Quality Index (PSQI). The sessions will be held three times a week over 12 weeks Baseline assessment (before initiation of intervention), intermediate assessment (at 6 weeks of intervention), and final assessment (after completion of intervention) will be conducted. A single-blinded Randomized Controlled Trial approach will be adopted to assess the efficacy of intervention on sleep among students. The assessment tools include pre- validated Harvard step test to examine cardiac fitness. Pittsburgh Sleep Quality Index (PSQI) to study sleep quality, Sleep Disorders Symptom Checklist (SDS-CL)-17 for examining the presence of symptoms of sleep disorder, and Menstrual Distress Questionnaire (MEDI-Q) to assess Menstrual distress among females. Lifestyle and screen time exposure assessment will be performed by using self- structured and validated tool.

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
Participant Blinded

Eligibility Criteria

Ages
18.00 Year(s) to 24.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Enrolled in any undergraduate course in an educational institute under the boundaries of National Capital, Delhi.
  • Understands English.
  • Provide consent to participate.

Exclusion Criteria

  • Student with any reported psychiatric disorder.
  • Do not understand English.

Outcomes

Primary Outcomes

The primary outcome includes improvement in sleep latency, sleep duration, sleep efficiency, and sleep quality.

Time Frame: Baseline assessment (before initiation of intervention), intermediate assessment (at 6-weeks of intervention) and final assessment (at 12 weeks after completion of intervention).

Secondary Outcomes

  • The secondary outcome includes raised knowledge and awareness of sleep and its significance for health and overall productivity.(Baseline assessment (before initiation of intervention), intermediate assessment (at 6-weeks of intervention) and final assessment (at 12 weeks after completion of intervention).)

Investigators

Sponsor
Delhi Pharmaceutical Sciences and Research University
Sponsor Class
Other [Government University]
Responsible Party
Principal Investigator
Principal Investigator

Dr Puneeta Ajmera

Delhi Pharmaceutical Sciences and Research University

Study Sites (1)

Loading locations...

Similar Trials